• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2020, Vol. 37 ›› Issue (3): 211-214.

• 药品评价 • 上一篇    下一篇

银黄制剂抗感染作用与临床应用进展

冯群1, 关永霞1,2, 姚景春2, 李艳芳1,2, 张贵民2*   

  1. 1. 鲁南厚普制药有限公司, 山东 临沂 276006;
    2. 鲁南制药集团股份有限公司 中药制药共性技术国家重点实验室, 山东 临沂 276006
  • 收稿日期:2020-04-07 修回日期:2020-05-10 出版日期:2020-06-28 发布日期:2020-07-15
  • 基金资助:
    山东省重点研发计划(重大科技创新工程)项目(2017CXGC1308)

Progress of Yinhuang Preparations on Anti-infectious Activities and Clinical Applications

  1. 1. Lunan Hope Pharmaceutical Co., Ltd.,Shandong Linyi 276006, China;
    2. Lunan Pharmaceutical Group Co., Ltd., State Key Laboratory of Generic Manufacture Technology of
         Chinese Traditional Medicine,Shandong Linyi 276006, China
  • Received:2020-04-07 Revised:2020-05-10 Online:2020-06-28 Published:2020-07-15

摘要: 银黄制剂是由金银花、黄芩2种药材的提取物组成,其上市产品涉及注射剂和口服两类剂型,具有清热疏风,利咽解毒等功效,临床广泛应用于上呼吸道感染、急慢性咽炎、急慢性扁桃体炎等外感性疾病。本研究从现代药理学研究和临床应用等方面对银黄制剂抗感染作用的研究进展予以综述,以期对其上市后再评价研究及应用提供参考。

关键词: font-size:medium, ">银黄制剂;抗菌;抗病毒;临床应用

Abstract: bjective: Yinhuang preparations, consisting of the extractions of Flos Lonicerae and Radix Scutellariae, have the effects of clearing heat and detoxifying, expelling wind and relieving sore throat. The marketed products, which are mainly divided into injections and oral preparations, are widely used in clinic for exopathogenic diseases, including upper respiratory infection, acute and chronic rhinitis, amygdalitis, etc. The present study reviews the anti-infectious researches of Yinhuang preparations on pharmacology and clinical applications to provide a useful reference for the clinical use in the post-marketed drug reassessment.

Key words: font-size:medium, ">Yinhuang preparation; Antibacterial action; Antiviral effect; Clinical application

中图分类号: